...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Exempt Distribution- 2023-03-31
Reply New Message
Back To Forum List View
Additional Exempt Distribution- 2023-03-31
5
KOO-KOO2
Apr 10, 2023 07:09PM

What's up with a number of new warrants expiring in Nov 2023? That seems interesting, maybe? 

1 Recommendations
Re: Additional Exempt Distribution- 2023-03-31
1
KayakerBC
Apr 12, 2023 09:49AM
Re: Additional Exempt Distribution- 2023-03-31
4
KOO-KOO2
Apr 12, 2023 10:54AM
Re: Additional Exempt Distribution- 2023-03-31
3
KayakerBC
Apr 12, 2023 12:38PM
Icon president Re: Additional Exempt Distribution- 2023-03-31
4
Nextblockbuster
Apr 15, 2023 03:53PM
Re: Additional Exempt Distribution- 2023-03-31
1
KayakerBC
Apr 16, 2023 06:56PM
Icon president Re: Additional Exempt Distribution- 2023-03-31
4
Nextblockbuster
Apr 16, 2023 07:45PM
Re: Additional Exempt Distribution- 2023-03-31
3
tada
Apr 16, 2023 07:53PM
Icon president Re: Additional Exempt Distribution- 2023-03-31
2
Nextblockbuster
Apr 17, 2023 07:01AM
Icon president Re: Additional Exempt Distribution- 2023-03-31
5
RVXoldtimer
Apr 17, 2023 07:15PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply